Dr. Angela M. Eakin, MD
Family Medicine (Family Medicine Physician)
6002 N Lidgerwood St
Spokane, WA 99208
Who else practices at this address →
Spokane County includes primary care (67% of residents) and dental (43% of residents) and mental health (29% of residents) shortage areas. About shortage areas
At a glance
- In the NPI registry since
- 2012
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Medicine Physician primary
DC license MD042953 -
Student in an Organized Health Care Education/Training Program
WA license ML60296568
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $1,692,746 in research payments for these studies, mostly to the institutions running them.
- TRIPHA TRN-228-102 Human Abuse Potential P1_CDMPQRSX
Tris Pharma Inc - A Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 Study to Evaluate Impact of Sunobinop (V117957) on Alcohol Consumption in Subjects Diagnosed with Moderate to Severe Alcohol Use Disorder and Seek…
Imbrium Therapeutics L.P. - A Phase 1, Open-label, Randomized, Parallel Group Study to Assess the Relative Bioavailability of Maridebart Cafraglutide (AMG 133) as Two Subcutaneous Presentations in Participants Living With Overweight or Obesity
Amgen Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.